Clean Break: the company completely halting Russian engagements or exiting Russia
Leave Withdrawal
Eli Lilly
Eli Lilly
Eli Lilly and Company is an American pharmaceutical company.
Clean Break: the company completely halting Russian engagements or exiting Russia
Leave WithdrawalRevenue(RF), mln.USD
124
Assets(RF), mln.USD
107
Capital(RF), mln.USD
68
Glob.Revenue, mln.USD
28318
Staff(RF), 2021
147
Taxes(RF), mln.USD
3
The Company Statement
April 11, 2023
Suspend new investments and clinical trials. The American pharmaceutical company Eli Lilly has decided to leave Russia and transfer its business to its partner in Central and Eastern Europe — the Swiss-registered distributor Swixx Biopharma. The company will hand over business in the country to Swixx BioPharma. Through it, Eli Lilly will continue to supply drugs to Russia.
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner